← FDA DRUG APPROVALS

FDA ANDA · ANDA087226

PHENTERMINE HYDROCHLORIDE

Sponsor: CAMALL

APPLICATION
ANDA087226
TYPE
ANDA
ORIGINAL APPROVAL
1980-09-10
LATEST ACTION
1998-11-03
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

PHENTERMINE HYDROCHLORIDEDiscontinued
PHENTERMINE HYDROCHLORIDE 30MG · CAPSULE · ORAL

Approval history

1998-11-03Labeling · Supplement 20AP
1998-08-19Labeling · Supplement 19AP
1998-04-08Labeling · Supplement 18AP
1997-12-19Labeling · Supplement 17AP
1992-10-16Manufacturing (CMC) · Supplement 16AP
1989-09-12Labeling · Supplement 14AP
1988-06-27Manufacturing (CMC) · Supplement 13AP
1988-06-27Manufacturing (CMC) · Supplement 12AP
1984-04-25Manufacturing (CMC) · Supplement 10AP
1983-12-22Manufacturing (CMC) · Supplement 9AP
1983-12-22Manufacturing (CMC) · Supplement 8AP
1983-04-28Manufacturing (CMC) · Supplement 5AP
1980-09-10OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →